Financial Results for the Year Ended 30 June 2026

• Underlying NPAT up 23% (cc) reflecting performance momentum in Australia and operational improvements across all regions
• Australian transformation building momentum, with underlying EBIT growth of 11.2%
• Ramsay UK & Elysium reported EBIT growth despite soft NHS volumes
• Ramsay Santé separation proposal on track, subject to shareholder vote in November
• Fully franked final dividend of 48.5¢ determined +21.3% on pcp

Ramsay Health Care Ltd announced its financial results for the year ended 30 June 2026, showing a 23% (cc) increase in underlying Net Profit after Tax (NPAT) to A$364.1 million. The Australian business delivered underlying EBIT growth of 11.2% and margin expansion of 30 basis points, driven by activity growth, higher acuity, and improved revenue indexation. Ramsay UK & Elysium reported EBIT growth despite a decline in NHS volumes, focusing on higher acuity work and cost management. The proposed separation of Ramsay Santé is on track, subject to a shareholder vote in November, aiming to simplify the portfolio and focus on core Australian operations. The company also announced a fully franked final dividend of 48.5 cents per share, a 21.3% increase on the previous corresponding period.

FY27: EBIT growth expected in Australia and UK businesses, total capex $480-520m, dividend payout ratio 60-70%

Ramsay Health Care Ltd expects EBIT growth and margin improvement in FY27, with positive momentum in Australia and UK businesses. The company anticipates a net financing expense of $280-300 million and an effective tax rate of ~30%.